Literature DB >> 25106849

West Nile and st. Louis encephalitis viruses antibodies surveillance in captive and free-ranging birds of prey from Argentina.

Agustin I Quaglia1, Luis A Diaz, Hernan Argibay, Marta S Contigiani, Miguel D Saggese.   

Abstract

We evaluated the prevalence of WNV and SLEV neutralizing antibodies in captive and free-ranging raptors from Argentina by plaque-reduction neutralization test. Eighty plasma samples from 12 species were analyzed. Only one captive adult Crowned Eagle (Harpyhaliaetus coronatus) was WNV seropositive (prevalence: 1.25%; antibody titer of 1:80). Two captive Crowned Eagles were SLEV seropositive (prevalence: 2.50%; antibody titers: 1:80 and 1:40).These findings expand the geographic distribution of WNV and SLEV and confirm their activity in central and northeastern Argentina. West Nile virus activity in Argentina may represent a potential threat to Crowned Eagles and other endangered raptors in this country.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25106849     DOI: 10.1007/s10393-014-0956-5

Source DB:  PubMed          Journal:  Ecohealth        ISSN: 1612-9202            Impact factor:   3.184


  26 in total

Review 1.  Epidemiology of St. Louis encephalitis virus.

Authors:  William K Reisen
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

2.  Pathology and epidemiology of natural West Nile viral infection of raptors in Georgia.

Authors:  Angela E Ellis; Daniel G Mead; Andrew B Allison; David E Stallknecht; Elizabeth W Howerth
Journal:  J Wildl Dis       Date:  2007-04       Impact factor: 1.535

3.  West Nile virus in the endangered Spanish imperial eagle.

Authors:  Ursula Höfle; Juan M Blanco; Elena Crespo; Victoria Naranjo; Miguel Angel Jiménez-Clavero; Azucena Sanchez; José de la Fuente; Christian Gortazar
Journal:  Vet Microbiol       Date:  2007-11-17       Impact factor: 3.293

4.  [Saint Louis encephalitis virus in Buenos Aires city during the outbreak of dengue in 2009].

Authors:  Horacio López; Jorge Neira; María Alejandra Morales; Cintia Fabbri; María Laura D'Agostino; Teresa Zitto
Journal:  Medicina (B Aires)       Date:  2011       Impact factor: 0.653

5.  Natural and experimental West Nile virus infection in five raptor species.

Authors:  Nicole Nemeth; Daniel Gould; Richard Bowen; Nicholas Komar
Journal:  J Wildl Dis       Date:  2006-01       Impact factor: 1.535

6.  Zoological institution participation in a West Nile Virus surveillance system: implications for public health.

Authors:  E Pultorak; Y Nadler; D Travis; A Glaser; T McNamara; S D Mehta
Journal:  Public Health       Date:  2011-07-19       Impact factor: 2.427

Review 7.  Transmission dynamics and changing epidemiology of West Nile virus.

Authors:  Bradley J Blitvich
Journal:  Anim Health Res Rev       Date:  2008-03-19       Impact factor: 2.615

8.  Evidence for regular ongoing introductions of mosquito disease vectors into the Galapagos Islands.

Authors:  Arnaud Bataille; Andrew A Cunningham; Virna Cedeño; Marilyn Cruz; Gillian Eastwood; Dina M Fonseca; Charlotte E Causton; Ronal Azuero; Jose Loayza; Jose D Cruz Martinez; Simon J Goodman
Journal:  Proc Biol Sci       Date:  2009-08-12       Impact factor: 5.349

9.  Clinical evaluation and outcomes of naturally acquired West Nile virus infection in raptors.

Authors:  Nicole M Nemeth; Gail E Kratz; Rebecca Bates; Judy A Scherpelz; Richard A Bowen; Nicholas Komar
Journal:  J Zoo Wildl Med       Date:  2009-03       Impact factor: 0.776

10.  Surveillance for West Nile virus in clinic-admitted raptors, Colorado.

Authors:  Nicole Nemeth; Gail Kratz; Eric Edwards; Judy Scherpelz; Richard Bowen; Nicholas Komar
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

View more
  1 in total

1.  Evaluation of Argentinean Bird Species as Amplifying Hosts for St. Louis Encephalitis Virus (Flavivirus, Flaviviridae).

Authors:  Adrián Díaz; Fernando S Flores; Agustín I Quaglia; Marta S Contigiani
Journal:  Am J Trop Med Hyg       Date:  2018-05-10       Impact factor: 2.345

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.